Profound Medical Analyst Ratings
Profound Medical Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/04/2022 | — | Raymond James | Upgrades | Outperform → Strong Buy | |
| 03/07/2022 | 207.69% | Cowen & Co. | $28 → $14 | Maintains | Outperform |
| 02/22/2022 | 405.49% | Raymond James | $28 → $23 | Downgrades | Strong Buy → Outperform |
| 09/15/2020 | — | Jefferies | Initiates Coverage On | → Buy | |
| 09/10/2020 | 383.52% | Lake Street | → $22 | Initiates Coverage On | → Buy |
| 04/01/2020 | 229.67% | Cowen & Co. | → $15 | Initiates Coverage On | → Outperform |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
|---|---|---|---|---|---|
| 2022 年 4 月 11 日 | — | 雷蒙德·詹姆 | 升级 | 跑赢大盘 → 强势买入 | |
| 03/07/2022 | 207.69% | Cowen & Co. | 28 美元 → 14 美元 | 维护 | 跑赢大盘 |
| 02/22/2022 | 405.49% | 雷蒙德·詹姆 | 28 美元 → 23 美元 | 降级 | 强势买入 → 跑赢大盘 |
| 2020 年 9 月 15 日 | — | 杰富瑞集团 | 启动覆盖范围开启 | → 购买 | |
| 2020 年 10 月 9 日 | 383.52% | 湖街 | → 22 美元 | 启动覆盖范围开启 | → 购买 |
| 2020 年 1 月 4 日 | 229.67% | Cowen & Co. | → 15 美元 | 启动覆盖范围开启 | → 跑赢大盘 |
Profound Medical Questions & Answers
深刻的医学问题与解答
The latest price target for Profound Medical (NASDAQ: PROF) was reported by Raymond James on November 4, 2022. The analyst firm set a price target for $0.00 expecting PROF to fall to within 12 months (a possible -100.00% downside). 3 analyst firms have reported ratings in the last year.
雷蒙德·詹姆斯于2022年11月4日公布了Profound Medical（纳斯达克股票代码：PROF）的最新目标股价。该分析公司将目标股价定为0.00美元，预计PROF将在12个月内降至12个月内（可能下跌-100.00％）。去年有3家分析公司公布了评级。
The latest analyst rating for Profound Medical (NASDAQ: PROF) was provided by Raymond James, and Profound Medical upgraded their strong buy rating.
雷蒙德·詹姆斯对Profound Medical（纳斯达克股票代码：PROF）的最新分析师评级由雷蒙德·詹姆斯提供，而Profound Medical则上调了
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Profound Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Profound Medical was filed on November 4, 2022 so you should expect the next rating to be made available sometime around November 4, 2023.
分析师在进行了广泛的研究后得出了股票评级，其中包括浏览公开财务报表，与Profound Medical的高管和客户交谈，以及听取财报电话会议。大多数分析师每三个月做一次这样的评级，因此每家公司每年应该获得4次评级。Profound Medical的最新评级是在2022年11月4日发布的，因此您应该预计下一个评级将在2023年11月4日左右公布。
While ratings are subjective and will change, the latest Profound Medical (PROF) rating was a upgraded with a price target of $0.00 to $0.00. The current price Profound Medical (PROF) is trading at is $4.55, which is out of the analyst's predicted range.
尽管评级是主观的，并且会发生变化，但最新的Profound Medical（PROF）评级已上调，目标股价为0.00美元至0.00美元。Profound Medical（PROF）目前的交易价格为4.55美元，超出了分析师的预期区间。